Dr Annalisa Jenkins is a life science thought leader. She was previously Head of Global R and D at Merck Serono and SVP Head of Global Medical at Bristol Myers Squibb. More recently she led Dimension Therapeutics that she took through to a NASDAQ listing and a subsequent sale to Ultragenyx.